1,015
Views
84
CrossRef citations to date
0
Altmetric
Original Article

A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson’s disease

, , , , , , , , , , , & show all
Pages 129-137 | Received 16 Apr 2015, Accepted 01 Nov 2015, Published online: 03 Dec 2015

References

  • Bartel DP. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–97
  • Botta-Orfila T, Morato X, Compta Y, et al. (2014). Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease. J Neurosci Res 92:1071–7
  • Burgos K, Malenica I, Metpally R, et al. (2014). Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology. PLoS One 9:e94839
  • Bustin SA, Benes V, Garson JA, et al. (2009). The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55:611–22
  • Cardo LF, Coto E, de Mena L, et al. (2013). Profile of microRNAs in the plasma of Parkinson's disease patients and healthy controls. J Neurol 260:1420–2
  • Chaudhuri KR, Martinez-Martin P, Schapira AHV, et al. (2006). International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Mov Disord 21:916–23
  • Chen X, Ba Y, Ma L, et al. (2008). Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18:997–1006
  • Chen X, Hu Z, Wang W, et al. (2012). Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis. Int J Cancer 130:1620–8
  • Chen YP, Song W, Huang R, et al. (2013). GAK rs1564282 and DGKQ rs11248060 increase the risk for Parkinson's disease in a Chinese population. J Clin Neurosci 20:880–3
  • Cogswell JP, Ward J, Taylor IA, et al. (2008). Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis 14:27–41
  • Doxakis E. (2010). Post-transcriptional regulation of alpha-Synuclein expression by mir-7 and mir-153. J Biol Chem 285:12726–34
  • Fang C, Zhu DX, Dong HJ, et al. (2011). Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma. Ann Hematol 91:553–9
  • Geekiyanage H, Jicha GA, Nelson PT, et al. (2012). Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease. Exp Neurol 235:491–6
  • Gilad S, Meiri E, Yogev Y, et al. (2008). Serum microRNAs are promising novel biomarkers. Plos One 3:e3148
  • Harraz MM, Dawson TM, Dawson VL. (2011). MicroRNAs in Parkinson's disease. J Chem Neuroanat 42:127–30
  • Hassan M, Sehgal SA, Rashid S. (2014). Regulatory cascade of neuronal loss and glucose metabolism. CNS Neurol Disord Drug Targets 13:1232–45
  • Huggett JF, Foy CA, Benes V, et al. (2013). The digital MIQE guidelines: minimum information for publication of quantitative digital PCR experiments. Clin Chem 59:892–902
  • Isik S, Zaim M, Yildiz MT, et al. (2015). DNA topoisomerase IIβ as a molecular switch in neural differentiation of mesenchymal stem cells. Ann Hematol 94:307–18
  • Kanoh H, Yamada K, Sakane F. (2002). Diacylglycerol kinases: emerging downstream regulators in cell signaling systems. J Biochem 131:629–33
  • Kim J, Inoue K, Ishii J, et al. (2007). A microRNA feedback circuit in midbrain dopamine neurons. Science 317:1220–4
  • Khoo SK, Petillo D, Kang UJ, et al. (2012). Plasma-based circulating MicroRNA biomarkers for Parkinson's disease. J Parkinsons Dis 2:321–31
  • Liu R, Chen X, Du Y, et al. (2012). Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. Clin Chem 58:610–8
  • Luo Y, Wang C, Chen X, et al. (2013). Increased serum and urinary microRNAs in children with idiopathic nephrotic syndrome. Clin Chem 59:658–66
  • Martinezmartin P, Gilnagel A, Gracia LM, et al. (1994). Unified Parkinson's Disease Rating Scale characteristics and structure. The Cooperative Multicentric Group. Mov Disord 9:76–83
  • Mitchell PS, Parkin RK, Kroh EM, et al. (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105:10513–8
  • Mizuno H, Nakamura A, Aoki Y, et al. (2011). Identification of muscle-specific MicroRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophy. PLoS One 6:e18388
  • Ng EK, Chong WW, Jin H, et al. (2009). Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58:1375–81
  • Pankratz N, Wilk JB, Latourelle JC, et al. (2009). Genomewide association study for susceptibility genes contributing to familial Parkinson disease. Hum Genet 124:593–605
  • Parisi C, Arisi I, D'Ambrosi N, et al. (2013). Dysregulated microRNAs in amyotrophic lateral sclerosis microglia modulate genes linked to neuroinflammation. Cell Death Dis 4:e959
  • Resnick KE, Alder H, Hagan JP, et al. (2009). The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 112:55–9
  • Saito M, Maruyama M, Ikeuchi K, et al. (2000). Autosomal recessive juvenile parkinsonism. Brain Dev 22 Suppl 1:S115–17
  • Shimura H, Hattori N, Kubo S, et al. (2000). Familial Parkinson disease gene product, Parkin, is a ubiquitin-protein ligase. Nat Genet 25:302–5
  • Tabellini G, Billi AM, Falà F, et al. (2004). Nuclear diacylglycerol kinase-theta is activated in response to nerve growth factor stimulation of PC12 cells. Cell Signal 16:1263–71
  • Vallelunga A, Ragusa M, Di Mauro S, et al. (2014). Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and multiple system atrophy. Front Cell Neurosci 8:156
  • Wang J, Chen J, Chang P, et al. (2009). MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev Res (Phila) 2:807–13
  • Wang J, Hoekstra JG, Zuo C, et al. (2013). Biomarkers of Parkinson's disease: current status and future perspectives. Drug Discov Today 18:155–62
  • Wu CY, Wang C, Guan XC, et al. (2014). Diagnostic and prognostic implications of a serum miRNA panel in oesophageal squamous cell carcinoma. PLoS One 9:e92292
  • Yang C, Wang C, Chen X, et al. (2013). Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas. Int J Cancer 132:116–27
  • Zampetaki A, Kiechl S, Drozdov I, et al. (2010). Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 107:810–7
  • Zhang CN, Wang C, Chen X, et al. (2010). Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma. Clin Chem 56:1871–9
  • Zimprich A, Biskup S, Leitner P, et al. (2004). Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology. Neuron 44:601–7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.